Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
Cell 2013 Jun 6A clinically efficacious Ras inhibitor has eluded drug-discovery efforts for decades. In a paper in Nature, Zimmermann and et al. show that blocking a hole in PDEδ that normally engages the lipid tail of Ras disrupts downstream signaling, pointing to a potentially promising route to develop Ras inhibitors for cancer treatment. Copyright © 2013 Elsevier Inc. All rights reserved.
Jeffrey S Iwig, John Kuriyan. Fixing a hole where the Ras gets in. Cell. 2013 Jun 6;153(6):1191-3
PMID: 23746837
View Full Text